I wonder if once we have completed the 28 day, if all of the remaining placebo patients will be allowed to get Vyrologix. I sure hope so.

This creates a couple of interesting sceanrios.

First, the trial site doctors may be able to witness the change in those patients.

Secondly, if this was allowed I would imagine it would eliminate the ability to use post 28 day data, or atleast affect the ability to.